Amgen, colorectal cancer

US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation. Amgen's Lumakras in combination with Vectibix was approved to treat adult patients whose cancer has spread to other parts of the body despite receiving chemotherapy,
FDA approves therapies for colorectal cancer, mantle cell lymphoma
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients with mantle cell lymphoma.
Looking Beyond Obesity, Amgen Wins Colorectal Cancer Expansion for Lumakras
The Phase III CodeBreaK 300 study returned disappointing overall survival data for Lumakras plus Vectibix in metastatic colorectal cancer, but in its approval announcement, the FDA pointed to significant improvements in progression-free survival,
Amgen's Lumakras+Vectibix Combo Gets FDA Approval For Metastatic Colorectal Cancer Treatment
Friday announced that the U.S. Food and Drug Administration has approved its Lumakras plus Vectibix combination
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
The U.S. Food and Drug Administration (FDA) has approved Amgen’s (NASDAQ:AMGN) KRASG12C inhibitor Lumakras as part of a combination regimen for adults with metastatic colorectal cancer (mCRC) whose tumors harbor an abnormal gene known as KRAS G12C.
Cure Today5h
Carrying the Torch: From Colorectal Cancer Survivor to Advocate
As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their ...
Having this body shape means you’re more at risk for colorectal cancer, diabetes and heart disease
Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...
Hosted on MSN1d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
"The trial shows that aspirin is well tolerated in this patient group but does not demonstrate a significant reduction in ...
Drinking a glass of milk daily can help reduce risk of colorectal cancer, says study
Reduce your risk of colorectal cancer with a simple daily habit! Drinking a glass of milk every day may help lower your risk, ...
Rolling Out5d
This drug can lower risk of colorectal cancer by 18%
Study of 107,000 participants demonstrates regular aspirin use significantly reduces colorectal cancer risk, especially in ...
A glass of milk's worth of calcium has been linked to a lower colorectal cancer risk. Here are 6 foods you might not know contain the mineral.
In a study of 542,000 women, consuming the amount of calcium found in a glass of milk a day was linked to a lower colorectal ...
The American Journal of Managed Care1d
Prioritizing Blood-Based Colorectal Cancer Tests May Lead to Higher Costs, Worse Outcomes
Despite the availability of several noninvasive tests for colorectal cancer, prioritizing blood-based tests may result in ...
Rolling Out12d
New blood test that could change colorectal cancer screening
A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...
Medscape10h
‘Alarming Disparities’ in Cancer Trends and Shift to Women, Younger Adults
Annual cancer statistics report identifies persistent racial and ethnic disparities and increases in certain cancers in women ...
Cancer Rates Are 82% Higher in Young Women than Men: 'Something Broader Is Going On'
Cancer rates for young women are sharply rising, with women under 50 more likely to develop cancer than their male ...